Jove
Visualize
Contact Us

Related Experiment Videos

A monitored-release study of methrazone in general practice.

P G Harris

    The Journal of International Medical Research
    |January 1, 1980
    PubMed
    Summary

    Methrazone, a non-steroidal anti-inflammatory drug, effectively treated rheumatoid and osteoarthritis in over 2,600 patients. While generally safe, some experienced adverse reactions, necessitating withdrawal in 11% of cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Achieving ultra-low and -uniform residual magnetic fields in a very large magnetically shielded room for fundamental physics experiments.

    The European physical journal. C, Particles and fields·2024
    Same author

    Publisher's Note: "The very large n2EDM magnetically shielded room with an exceptional performance for fundamental physics measurements" [Rev. Sci. Instrum. 93, 095105 (2022)].

    The Review of scientific instruments·2022
    Same author

    The very large n2EDM magnetically shielded room with an exceptional performance for fundamental physics measurements.

    The Review of scientific instruments·2022
    Same author

    A review of utilities and costs of treating upper extremity amputations with vascularized composite allotransplantation versus myoelectric prostheses in Canada.

    JPRAS open·2022
    Same author

    Data blinding for the nEDM experiment at PSI.

    The European physical journal. A, Hadrons and nuclei·2021
    Same author

    The design of the n2EDM experiment: nEDM Collaboration.

    The European physical journal. C, Particles and fields·2021
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Pharmacology
    • Rheumatology
    • Clinical Medicine

    Background:

    • Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for inflammatory conditions.
    • Understanding the efficacy and safety profile of specific NSAIDs in general practice is crucial for patient care.

    Purpose of the Study:

    • To evaluate the efficacy and safety of Methrazone in a large patient cohort within a general practice setting.
    • To assess the incidence of adverse reactions and identify potential drug interactions.

    Main Methods:

    • A monitored release study involving 2,693 patients diagnosed with rheumatoid or osteoarthritis.
    • Patients received Methrazone at a dosage of 200 mg three times daily.
    • Adverse reactions and treatment outcomes were systematically monitored.

    Main Results:

    • Methrazone demonstrated clear clinical benefit in 50-60% of patients treated.
    • Common adverse reactions included dyspepsia and skin rash, leading to drug withdrawal in 11% of patients.
    • Three major adverse reactions (haematemesis, rectal bleeding, acute purpura) were possibly drug-related; no severe leucopenia or thrombocytopenia observed.

    Conclusions:

    • Methrazone is an effective anti-inflammatory agent for rheumatoid and osteoarthritis.
    • The drug exhibits a favorable safety profile with a low incidence of severe adverse events.
    • Methrazone is unlikely to cause significant drug interactions, including with cardiac glycosides like digoxin.

    Related Experiment Videos